A previous investigation revealed that increased PAI-1 levels may play a role in the level of thrombosis and fibrin deposition exhibited in patients infected with COVID-19 [18], providing a possible therapeutic target for the development of COVID-19 treatments and interventions. The gene discussed is SERPINE1; the disease is deep vein thrombosis.